Showing promise in the arena of excess body fat treatment, retatrutide represents a distinct approach. Unlike many current medications, retatrutide functions as a double agonist, simultaneously affecting both glucagon-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic hormone (GIP) receptors. The dual stimulation encourages various advanta